医疗食品市场规模、份额和成长分析：按管理途径、按产品、按销售管道、按应用、按地区 - 行业预测，2024-2031 年

2022年，全球医疗食品市场规模为226亿美元，从2023年的237.8亿美元成长到2031年的356.7亿美元，预计在预测期内（2024-2031年）将成长。 。

由于老年痴呆症、过动症、骨质疏鬆症、骨关节炎和各种中枢神经神经病变等慢性疾病盛行率的上升，医疗食品市场正在经历显着增长。此外，医疗专业人员还建议针对睡眠障碍、忧郁症、纤维肌痛、创伤后压力症候群（PTSD）以及有特定营养需求或消化器官系统问题的患者使用基于氨基酸的经肠营养，并强调这些产品是为患者量身定制的。药物开发的进步和疾病特异性製剂的引入进一步促进了这种扩张。雀巢等行业领导者处于创建个人化临床营养解决方案的前沿，用于糖尿病管理的 Metanx 和用于治疗忧郁症。医疗食品越来越被认为是在医疗监督下结合药物和膳食食品元素的混合，可有效控制帕金森氏症和阿兹海默症疾病。医疗食品与传统营养食品之间的区别在于医疗食品经过严格的临床测试，这需要食品旨在解决的疾病状态有透彻的了解。随着医疗保健提供者评估患者的营养需求和健康状况，医疗食品越来越多地被推荐并获得消费者的认可和接受。这些因素导致当今医疗保健领域对医疗食品的受欢迎程度和需求迅速上升。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 价值链分析
• 案例研究分析
• PESTEL分析
• 总体经济指标
• 市场吸引力指数
• 价格分析

医疗食品市场：依管理途径

• 市场概况
• 口服
• 肠内

医疗食品市场：副产品

• 市场概况
• 粉末
• 锭剂
• 液体
• 其他的

医疗食品市场：依销售管道划分

• 市场概况
• 网上销售
• 零售
• 向机构投资者出售

医疗食品市场：依应用分类

• 市场概况
• 慢性肾臟病
• 轻度肝性脑病变
• 化疗引起的腹泻
• 病原体相关感染疾病
• 糖尿病神经病变
• ADHD
• 忧郁症
• 阿兹海默症
• 营养不良
• 罕见疾病
  • 酪胺酸血症
  • 嗜伊红性食道炎
  • FPIES
  • 苯酮尿症
  • MSUD
  • 高胱氨酸尿症
  • 其他的
• 伤口癒合
• 其他的

医疗食品市场：按地区

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 阿拉伯联合大公国国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Danone
• Nestle
• Abbott
• Targeted Medical Pharma Inc.（Physician Therapeutics LLC, a division of the company）
• Primus Pharmaceuticals Inc.
• Fresenius Kabi AG
• Kate Farms
• Ajinomoto Cambrooke
• Nutricia North America
• GlaxoSmithKline
• B. Braun Medical Inc.
• BioCare
• NutriScience Innovations
• Ajinomoto Health & Nutrition
• Baxter International
• Fresenius Kabi

结论和建议

Global Medical Foods Market size was valued at USD 22.60 billion in 2022 and is poised to grow from USD 23.78 billion in 2023 to USD 35.67 billion by 2031, growing at a CAGR of 5.20% during the forecast period (2024-2031).

The market for medical foods is experiencing significant growth, driven by the rising prevalence of chronic diseases such as Alzheimer's, ADHD, osteoporosis, osteoarthritis, and various central nervous system disorders. Additionally, medical professionals recommend amino acid-based enteral nutrition for conditions like sleep disorders, depression, fibromyalgia, and PTSD, highlighting the tailored nature of these products for patients with specific nutritional needs or digestive issues. This expansion is further fueled by advancements in drug development and the introduction of disease-specific formulations. Industry leaders, such as Nestle, have been at the forefront of creating personalized clinical nutrition solutions, evidenced by their products like Metanx for diabetes management and Deplin for addressing depression. Medical foods are increasingly recognized as hybrid entities that combine elements of pharmaceuticals and dietary supplements, administered under medical supervision to manage conditions such as Parkinson's and Alzheimer's disease effectively. The differentiation between medical foods and conventional nutritional supplements lies in the rigorous clinical testing that medical foods undergo, necessitating a thorough understanding of the conditions they are designed to address. As healthcare providers assess patients' nutritional needs and health conditions, medical foods are being increasingly recommended, enhancing their visibility and acceptance among consumers. These factors collectively contribute to the surging popularity and demand for medical foods in today's healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Foods market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Foods Market Segmental Analysis

Global Medical Foods Market is segmented into Route of Administration, Product, Sales Channel, Application, and region. By animal type, the market is classified into Oral, and Enteral. Depending on the product, it is categorized into Powder, Pills, Liquid, and Other. According to end user, the market is divided into Online Sales, Retail Sales, and Institutional Sales. By Application, the market is segmented into Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Medical Foods Market

The global Medical Foods market is driven by the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and metabolic disorders. As these health issues become more widespread, there is a growing need for dietary interventions tailored to individual health requirements. Medical foods play a crucial role in addressing these dietary needs, helping patients manage their symptoms effectively while promoting better health outcomes. By enhancing overall well-being and improving quality of life, the demand for these specialized nutritional products is set to rise significantly, underscoring the vital importance of medical foods in contemporary healthcare regimes.

Restraints in the Global Medical Foods Market

One of the key restraints in the Global Medical Foods market is the lack of education and awareness among medical professionals, patients, and caregivers regarding the significance and benefits of medical foods. Without effective communication and educational efforts, the acceptance and adoption of these products can be hindered. Many healthcare providers may not fully grasp the distinctions between medical foods, dietary supplements, and conventional foods, which can negatively impact prescription practices and ultimately affect patient outcomes. Therefore, enhancing knowledge and understanding in this area is crucial for improving the utilization of medical foods and ensuring they are appropriately integrated into patient care.

Market Trends of the Global Medical Foods Market

The Global Medical Foods market is experiencing significant growth driven by an increasing emphasis on chronic disease management, highlighting the pivotal role of medical foods in treating conditions such as diabetes, Alzheimer's disease, and gastrointestinal disorders. As healthcare systems prioritize preventative approaches and integrated care models, the demand for specialized nutritional products designed to target metabolic pathways and address specific dietary deficiencies is escalating. This trend underscores a transformative shift towards holistic treatment methodologies that combine medical and nutritional therapy, making medical foods a crucial component in the strategy to enhance patient outcomes and reduce healthcare costs globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index
• Pricing Analysis

Global Medical Foods Market Size by Route of Administration & CAGR (2024-2031)

• Market Overview
• Oral
• Enteral

Global Medical Foods Market Size by Product & CAGR (2024-2031)

• Market Overview
• Powder
• Pills
• Liquid
• Other

Global Medical Foods Market Size by Sales Channel & CAGR (2024-2031)

• Market Overview
• Online Sales
• Retail Sales
• Institutional Sales

Global Medical Foods Market Size by Application & CAGR (2024-2031)

• Market Overview
• Chronic Kidney Disease
• Minimal Hepatic Encephalopathy
• Chemotherapy Induced Diarrhoea
• Pathogen Related Infections
• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer's Disease
• Nutritional Deficiency
• Orphan Diseases
  • Tyrosinemia
  • Eosinophilic Esophagitis
  • FPIES
  • Phenylketonuria
  • MSUD
  • Homocystinuria
  • Others
• Wound Healing
• Others

Global Medical Foods Market Size & CAGR (2024-2031)

• North America, (Route of Administration, Product, Sales Channel, Application)
  • US
  • Canada
• Europe, (Route of Administration, Product, Sales Channel, Application)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Route of Administration, Product, Sales Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Route of Administration, Product, Sales Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Route of Administration, Product, Sales Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Danone
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primus Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kate Farms
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Cambrooke
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutricia North America
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NutriScience Innovations
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Health & Nutrition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation